- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Ethical AI Practices
In this Pharm Exec Podcast episode, Gerald Kierce, co founder and CEO of Trustible, and Andrew Camino Chung, the company's CTO and co founder, delve into the realm of artificial intelligence, discussing Trustible's mission and its pioneering efforts to ensure ethical AI use, particularly in the pharmaceutical industry, and how it navigates complex AI regulations across the globe.
Gerald Kierce, co founder and CEO of Trustible and Andrew Gamino-Cheong, the company's CTO and co founder, discuss their company mission and its pioneering efforts to ensure ethical AI use particularly in the pharmaceutical industry, and how it navigates complex AI regulations across the globe. They also explore the delicate balance between AI transparency and proprietary protection, their proactive approach towards AI ethics, and the strategic roadmap for the future.
About the speakers
Gerald Kierce is the Co-Founder & CEO of Trustible – a leading technology provider of responsible AI governance. Its software platform enables AI and compliance teams to scale their AI Governance programs to help build trust, manage risk, and comply with AI regulations.
Prior to founding Trustible, Gerald was an executive at FiscalNote (NYSE: NOTE) where he spent nearly a decade at the company across a variety of roles including VP & General Manager of their AI Solutions division, Corporate Development, Chief of Staff, Product Marketing, and Customer Success. FiscalNote was the most recent DC-based company to go public in the New York Stock Exchange in August of 2022. He is originally from San Juan, Puerto Rico.
Andrew Gamino-Cheong is the Co-Founder & CTO of Trustible – a leading technology provider of responsible AI governance. Its software platform enables AI and compliance teams to scale their AI Governance programs to help build trust, manage risk, and comply with AI regulations.
Andrew has spent his career working at the intersection of policy and AI. Prior to founding Trustible, Andrew was a machine learning engineering tech led at FiscalNote (NYSE: NOTE), a DC based policy information services company, where he built AI systems to help organizations better understand and map regulatory risks, applying AI to the policy landscape. Now, at Trustible, he's flipped the script and is working to apply policy to the AI landscape. Andrew has a Bachelors degree from Georgetown University, where he double majored in Computer Science and Government, and a Masters in Computer Science from the University of Maryland College Park.
About the Pharm Exec Podcast
The editors of Pharmaceutical Executivebring you the latest commercial insights to master the science of success. Podcast episodes examine current trends, key conferences, and critical topics in the bio/pharmaceutical industry.
Listen to this podcast on SoundCloud, Spotify, Google Podcasts, or Apple Podcasts.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
